British Medical Association withdraws objection to Cass Review on puberty blockers – Gript

The trade union and expert group for doctors and medical students in the UK have withdrawn their opposition to the Cass Review into puberty blockers after being held out by members.

At the end of July, the British Medical Association (BMA) sparked controversy from hundreds of members after it rejected the study’s findings and called for the ban on puberty blockers to be lifted. This caused many experienced doctors to withdraw from the association.

While the Cass Review’s findings were widely accepted, the BMA had vowed to set up a panel to “publicly criticize” the report, which the organization said contained “unsubstantiated recommendations.” The organization says it is “discriminatory” to prevent children and teenagers from accessing youth blockers.

The BMA council, which has 69 members, was asked to vote on a motion rejecting the Cass Review – which was passed and became policy.

However, more than 1,400 doctors, including 900 BMA members, responded, signing an open letter calling on the organization to accept the results of the review. In the letter, the doctors’ group said that BMA leaders “are against the principles of evidence-based medicine and against ethical standards.”

The letter, first published by The Times in August, detailed how members were not consulted on the proposal, members describing the meeting as “secret.”

In the letter, medical leaders and doctors criticized the BMA’s position as “unacceptable,” adding that it reflected “the views of many members.”

The letter, which was addressed to Professor Philip Banfield, chairman of the BMA, said: “We write as doctors to say, ‘not in my name’. We are very disappointed that the BMA council has passed a motion to carry out a ‘review’ of the Cass review and to encourage objections to its recommendations.

The transmission of the movement was silent and secret. It does not show the opinions of wider members, whose opinions you did not seek. We understand that no information will be released about the vote tally and how councilors voted. That is a failure to be accountable to the members and is unacceptable. ”

The letter also suggested that the implementation of the Cass Review would be key to ensuring that children receive appropriate care, and said:is a comprehensive health care assessment for children with gender-related problems that has been performed”.

It also called on the BMA to “stop its pointless exercise” of criticizing the Cass review, adding: “By arguing against the best evidence we have, the BMA is going against the rules- the basis of evidence-based medicine versus ethical practice.”

It’s new a statement published on its website, in recent days, the BMA announced that members had recently voted “for the BMA to maintain a neutral position on the Review until that review is complete.”

In a statement, David Strain, chairman of the BMA’s Scientific Board, wrote:

“We will also review the actions implemented in the name of the Cass Review, what has been planned, and what remains to be done. In accordance with BMA principles, the analysis we produce will be shared for everyone to use. I don’t know, and I don’t know in advance what conclusion we will reach.

“By approaching this review with an open mind and a commitment to listening to all views, the BMA is committed to promoting an inclusive and inclusive healthcare environment. I understand that some members disagreed with our review, and I willing to hear and understand their concerns.

“However, it is important that we move beyond polarizing arguments and focus on the hard realities of those affected, to ensure that their needs are met with compassion and evidence-based care. Ts’ This process will contribute to an informed and compassionate approach to health care for children and young people with gender nonconformity and dysphoria, in line with the BMA’s principles of advance medical knowledge and improve patient care.”

The Cass review, written by pediatrician Dr Hilary Cass, was published in April. A landmark independent report has found that children in the UK are being “indoctrinated” – citing a lack of reliable evidence about the safety of transgender children.

A review of gender identity services for children and young people in Britain has warned that health care professionals are afraid to speak up about transgender services for children, and found that there are no evidence of contraceptives or hormonal drugs ‘buy time to think’ or ‘reduce the risk of suicide. ‘ in that group.

The report was drawn up amid concerns about the controversial provision of ‘equal care’ (where some aspects of mental health were not assessed or given adequate counseling for children), and a significant increase in children who came to clinics such as Tavistock which has now closed. seeking to be put on the path to sex reassignment therapy.

In response to the shocking review, NHS England has announced that it will no longer prescribe blockers to children and young people under the age of 18 as a treatment for gender dysphoria. In July, the UK High Court ruled that the ban was legal – after a devolution campaign group took legal action, arguing that the former British Health Secretary Beauty failed to communicate with patient groups and misused emergency procedures.

British Health Secretary Wes Streeting said he welcomed the court’s decision, saying children’s health care must be “evidence-led”.